The BIO Investor Forum assembles a select group of early- and late- stage companies, established and emerging public biotechs, and top public and private equity investors to explore investment trends and opportunities in life sciences.
In addition to expert-led workshops, panel discussions, and fireside chats focusing on industry trends, the conference features presentations by over 150 biotech companies poised to join the growth “watch list” in 2018, as well as a number of nonprofit and venture philanthropy organizations.
Now a staple at the Investor Forum, the 16th annual event will once again feature a series of Discovery Track presentations. A pricing level has been created for "pre-emerging" biotech companies wishing to participate in the BIO Investor Form. The presentations will focus on Seed and A-round companies incorporated after 2012 that have raised less than $25M total through October 2018. Companies in this track are also first-time presenters at this event and use biotechnology or related technologies for research and development of drug products or diagnostics. The typical audience for all presentations features public and private equity investors, research analysts, investment bankers and industry executives.
Approved companies have the option of having their presentation webcast.
Information for Prospective Companies:
For any questions regarding company presentations, contact us at email@example.com.